Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Chronic Stable Angina
Interventions
DRUG

Dilatrend SR capsule

single oral administration in period 1 or 2, 3 for each sequential group.

Trial Locations (1)

138-736

Asan Medcial Center, Songpa-gu

Sponsors
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY